• Serum Institute's Adar Poonawalla Says Research On For Monkeypox Vaccine

    Health
    Serum Institute's Adar Poonawalla Says Research On For Monkeypox Vaccine

    Digital Desk: Adar Poonawalla, CEO of Serum Institute of India,
    stated on Tuesday that his company is researching a monkeypox vaccine as
    instances in the nation are on the rise.



    During a meeting on Tuesday at the Nirman Bhawan in this city,
    Mr. Poonawalla is said to have given Union Health Minister Mansukh Mandaviya a
    briefing on the subject.



    Monkeypox has so far been documented in eight cases in India,
    the most recent being a guy from Delhi.



    Monkeypox virus has already been isolated from a patient's
    clinical specimen by the National Institute of Virology (NIV), a division of
    the Indian Council of Medical Research (ICMR) with headquarters in Pune.



    On July 27, the ICMR issued a call for expressions of interest
    (EOI), proposing to give the virus strain to interested vaccine producers,
    pharmaceutical businesses, and in-vitro diagnostic (IVD) facilities in India in
    exchange for the development of a homegrown vaccine and diagnostic tools.



    A task team on monkeypox has been established in the meantime to
    carefully monitor the developing situation in the nation and choose reaction
    strategies.



    Monkeypox has just been deemed a global public health emergency
    of international concern by the World Health Organization (WHO).



    The WHO describes monkeypox as a viral zoonosis, or a virus that
    spreads from animals to humans, having symptoms that are comparable to smallpox
    but are less severe clinically.



     



    Fever, rash, and swollen lymph nodes are the classic symptoms of
    monkeypox, which can also result in a variety of medical consequences. The
    condition often has a two- to four-week symptom duration and is self-limited.



    According to the Center's "Guidelines on Management of
    Monkeypox Disease," big respiratory droplets—which typically need
    prolonged close contact—are the main mechanism of human-to-human transmission.



    Indirect contact with lesion material, such as through
    contaminated clothing or linen of an infected individual, as well as direct
    touch with body fluids or lesions are other ways in which it can be spread.
    Animals can spread diseases to humans by biting or scratching them, or by
    preparing bush meat.



    Monkeypox typically has an incubation period of six to
    thirteen days and historically has a case fatality rate of up to 11% in the
    general population and greater in children. The case fatality rate has recently
    been between three and six percent.



    Lesions are among the symptoms, which typically appear one
    to three days after the commencement of a fever, continue for about two to four
    weeks, and are frequently reported as painful up until the point of healing,
    when they turn itchy. According to the guidelines, monkeypox is characterised
    by a marked preference for palms and soles.